Microfabrication and nanotechnology in stent design

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 3, Issue 3, 2011, Pages 256-268

  Martinez, Adam W ^a   Chaikof, Elliot L ^a,b,c,d  

^a Wallace H Coulter Department of Biomedical Engineering   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Georgia Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MATERIALS; ATHEROSCLEROTIC LESIONS; BENEFICIAL EFFECTS; DESIGN FEATURES; DRUG-ELUTING STENTS; ELASTIC RECOIL; HIGH RATE; INFLAMMATORY RESPONSE; INTRAVASCULAR STENTS; MATERIAL PROPERTY; MICROFABRICATION PROCESS; RESTENOSIS; STENT COATINGS; STENT DESIGN; STENTING; VASCULAR WALL; VESSEL WALLS;

DESIGN; MICROANALYSIS; MICROMACHINING; NANOTECHNOLOGY;

MICROFABRICATION;

MICROSPHERE; NANOPARTICLE;

CELL ADHESION; CELL GROWTH; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; EQUIPMENT DESIGN; LASER; MATERIAL COATING; MICROTECHNOLOGY; NANOTECHNOLOGY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; SURFACE PROPERTY; THROMBOSIS;

ANIMALS; BIOPHARMACEUTICS; MICROTECHNOLOGY; NANOTECHNOLOGY; PROSTHESIS DESIGN; STENTS; SURFACE PROPERTIES;

EID: 79953283178     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.123     Document Type: Review

References (116)

1. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006, 151:1260-1264.
2. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007, 116:2391-2398.
3. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
4. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007, 115:1051-1058.
5. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356:998-1008.
6. Kamath KR, Barry JJ, Miller KM. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 2006, 58:412-436.
7. Puskas JE, Munoz-Robledo LG, Hoerr RA, Foley J, Schmidt SP, Evancho-Chapman M, Dong JP, Frethem C, Haugstad G. Drug-eluting stent coatings. WIREs Nanomed Nanobiotech 2009, 1:451-462.
8. O'Brien B, Carroll W. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater 2009, 5:945-958.
9. Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: a materials perspective. Biomaterials 2007, 28:1689-1710.
10. Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: material and design considerations. Eur Radiol 2004, 14:292-301.
11. Waksman R. Update on bioabsorbable stents: from bench to clinical. J Interv Cardiol 2006, 19:414-421.
12. Reifart N, Morice MC, Silber S, Benit E, Hauptmann KE, de Sousa E, Webb J, Kaul U, Chan C, Thuesen L, et al. The NUGGET study: NIR ultra gold-gilded equivalency trial. Cathet Cardiovasc Interv 2004, 62:18-25.
13. Kastrati A, Schomig A, Dirschinger J, Mehilli J, von Welser N, Pache J, Schuhlen H, Schilling T, Schmitt C, Neumann F-J. Increased risk of restenosis after placement of gold-coated stents results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000, 101:2478-2483.
14. vom Dahl J, Haager PK, Grube E, Gross M, Beythien C, Kromer EP, Cattelaens N, Hamm CW, Hoffmann R, Reineke T, et al. Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. Am J Cardiol 2002, 89:801-805.
15. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, Meinertz T, Hamm CW. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000, 356:1895-1897.
16. Heintz C, Riepe G, Birken L, Kaiser E, Chakfe N, Morlock M, Delling G, Imig H. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? J Endovasc Ther 2001, 8:248-253.
17. O'Brien B, Carroll WM, Kelly MJ. Passivation of nitinol wire for vascular implants-a demonstration of the benefits. Biomaterials 2002, 23:1739-1748.
18. Chu CL, Wang RM, Yin LH, Pu YP, Dong YS, Guo C, Sheng XB, Lin PH, Chu PK. Surface treatment of NiTi shape memory alloy by modified advanced oxidation process. Trans Nonferrous Met Soc China 2009, 19:575-580.
19. Firstov GS, Vitchev RG, Kumar H, Blanpain B, Van Humbeeck J. Surface oxidation of NiTi shape memory alloy. Biomaterials 2002, 23:4863-4871.
20. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky AJ. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 2003, 92:463-466.
21. Sketch MH, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ; Driver Investigators. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005, 95:8-12.
22. Kathuria YP. Biocompatible metallic stent for medical therapy. Window Laser Med World 2003, 5287:52-61
23. Aguilar CA, Lu Y, Mao S, Chen SC. Direct micro-patterning of biodegradable polymers using ultraviolet and femtosecond lasers. Biomaterials 2005, 26:7642-7649.
24. Li M, Ishizuka M, Liu XB, Sugimoto Y, Ikeda N, Asakawa K. Nanostructuring in submicron-level waveguides with femtosecond laser pulses. Opt Commun 2002, 212:159-163.
25. Li CD, Nikumb S, Wong F. An optimal process of femtosecond laser cutting of NiTi shape memory alloy for fabrication of miniature devices. Opt Laser Eng 2006, 44:1078-1087.
26. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 2003, 89:651-656.
27. Xia M, Tu YL. An investigation of femtosecond laser micromachining. In: Proceedings of the 2005 International Conference on MEMS, NANO and Smart Systems, Banff, Alberta, Canada; 2005, 296-300.
28. Grabow N, Bunger CM, Schultze C, Schmohl K, Martin DP, Williams SF, Sternberg K, Schmitz KP. A biodegradable slotted tube stent based on poly(l-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng 2007, 35:2031-2038.
29. Grabow N, Schlun M, Sternberg K, Hakansson N, Kramer S, Schmitz KP. Mechanical properties of laser cut poly(l-lactide) micro-specimens: implications for stent design, manufacture, and sterilization. J Biomech Eng 2005, 127:25-31.
30. Lootz D, Behrend D, Kramer S, Freier T, Haubold A, Benkiesser G, Schmitz KP, Becher B. Laser cutting: influence on morphological and physicochemical properties of polyhydroxybutyrate. Biomaterials 2001, 22:2447-2452.
31. Tonshoff HK, Ostendorf A, Nolte S, Korte F, Bauer T. Micro-machining using femtosecond lasers. 1st International Symposium on Laser Precision Microfabrication, 2000 Saitama, Japan, 4088:136-139.
32. Kathuria YP. Laser microprocessing of metallic stent for medical therapy. J Mater Process Technol 2005, 170:545-550.
33. Chichkov BN, Momma C, Nolte S, vonAlvensleben F, Tunnermann A. Femtosecond, picosecond and nanosecond laser ablation of solids. Appl Phys A-Mater Sci & Process 1996, 63:109-115.
34. Takahata K, Gianchandani YB. A planar approach for manufacturing cardiac stents: design, fabrication, and mechanical evaluation. J Microelectromech Syst 2004, 13:933-939.
35. Takahata K, Gianchandani YB, Wise KD. Micromachined antenna stents and cuffs for monitoring intraluminal pressure and flow. J Microelectromech Syst 2006, 15:1289-1298.
36. Hodgson D. Fabrication, Heat Treatment, and Joining of Nintinol Components. In: SMST-2000: proceedings of the International Conference on Shape Memory and Superelastic Technologies. Pacific Grove, California, USA: SMST, The International Organization on Shape Memory and superelastic Technology; 2000.
37. Craig CH, Radisch HR, Trozera TA, Turner PC, Govier RD, Vesely EJ, Gokcen NA, Friend CM, Edwards MR. Development of a platinum-enhanced radiopaque stainless steel (PERSŜ®). Stainless Steels Med Surg Appl 2003, 1438:28-38.
38. Kuribayashi K, Tsuchiya K, You Z, Tomus D, Umemoto M, Ito T, Sasaki M. Self-deployable origami stent grafts as a biomedical application of Ni-rich TiNi shape memory alloy foil. Mater Sci Eng A Struct Mater Prop Microstruct Process 2006, 419:131-137.
39. de Miranda RL, Zamponi C, Quandt E. Fabrication of TiNi thin film stents. Smart Mater Struct 2009, 18:104010.
40. Rumpf H, Wipperfurth V, Zamponi C, Quandt E. Near net-shape fabrication of superelastic NiTi devices by sputtering and photoetching. Mater Trans 2006, 47:523-526.
41. Moravej M, Prima F, Fiset M, Mantovani D. Electroformed iron as new biomaterial for degradable stents: development process and structure-properties relationship. Acta Biomater 2010, 6:1726-1735.
42. Toloken S. Firms investing in angio-plastic solution. Plastics News 2005, 16:9-12.
43. Park JH, Davis S, Yoon YK, Prausnitz MR, Allen MG. Micromachined biodegradable microstructures. In: MEMS-03: IEEE the Sixteenth Annual International Conference on Micro Electro Mechanical Systems, Kyoto, Japan; 2003, 371-374.
44. Armani DK, Liu C. Mircofabrication technology for polycaprolactone, a biodegradable polymer. J Micromech Microeng 2000, 10:80-84.
45. Lafont A, Li SM, Garreau H, Cornhill F, Vert M. PLA stereocopolymers as sources of bioresorbable stents: Preliminary investigation in rabbit. J Biomed Mater Res B Appl Biomater 2006, 77B:349-356.
46. Grayson ACR, Choi IS, Tyler BM, Wang PP, Brem H, Cima MJ, Langer R. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2003, 2:767-772.
47. Ryu W, Fasching RJ, Vyakarnam M, Greco RS, Prinz FB. Microfabrication technology of biodegradable polymers for interconnecting microstructures. J Microelectromech Syst 2006, 15:1457-1465.
48. Chen MC, Liu CT, Tsai HW, Lai WY, Chang Y, Sung HW. Mechanical properties, drug eluting characteristics and in vivo performance of a genipin-crosslinked chitosan polymeric stent. Biomaterials 2009, 30:5560-5571.
49. Yamada A, Niikura F, Ikuta K. A three-dimensional microfabrication system for biodegradable polymers with high resolution and biocompatibility. J Micromech Microeng 2008, 18:025035.
50. Su SH, Chao RYN, Landau CL, Nelson KD, Timmons RB, Meidell RS, Eberhart RC. Expandable bioresorbable endovascular stent. I. Fabrication and properties. Ann Biomed Eng 2003, 31:667-677.
51. Han DW, Lee JJ, Jung DY, Park JC, Hyon SH. Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations. Biomed Mater 2009, 4:044104.
52. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004, 25:1330-1340.
53. Blindt R, Hoffmeister KM, Bienert H, Pfannschmitt O, Bartsch G, Thissen H, Klee D, Vom Dahl J. Development of a new biodegradable intravascular polymer stent with simultaneous incorporation of bioactive substances. Int J Artif Organs 1999, 22:843-853.
54. Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K, Baek N, Park K, Fishbein MC, Makkar R, Litvack F, et al. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 2003, 107:777-784.
55. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA, et al. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease. J Am Coll Cardiol 2008, 51:1543-1552.
56. Loya MC, Park E, Chen LH, Brammer KS, Jin S. Radially arrayed nanopillar formation on metallic stent wire surface via radio-frequency plasma. Acta Biomater 2010, 6:1671-1677.
57. Shen Y, Wang GX, Chen L, Li H, Yu P, Bai MJ, Zhang Q, Lee J, Yu QS. Investigation of surface endothelialization on biomedical nitinol (NiTi) alloy: effects of surface micropatterning combined with plasma nanocoatings. Acta Biomater 2009, 5:3593-3604.
58. Lewis F, Horny P, Hale P, Turgeon S, Tatoulian M, Mantovani D. Study of the adhesion of thin plasma fluorocarbon coatings resisting plastic deformation for stent applications. J Phys D Appl Phys 2008, 41:045310.
59. Chen CH, Yang MR, Wu SK. Polymerized hexamethyldisilazane coated on equiatomic TiNi shape memory alloy using DC-pulsed plasma assisted chemical vapor deposition. Surf Coatings Technol 2008, 202:2709-2714.
60. Hong YJ, Jeong MH, Kim W, Lim SY, Lee SH, Hong SN, Kim JH, Ahn YK, Cho JG, Park JC, et al. Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries. Am J Cardiol 2004, 94:1050-1054.
61. Yang ZL, Wang J, Luo RF, Maitz MF, Jing FJ, Sun H, Huang N. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials 2010, 31:2072-2083.
62. Song SJ, Kim KS, Kim KH, Li HJ, Kim JH, Jeong MH, Kim BH, Ko YM, Cho DL. Preparation of a biocompatible stent surface by plasma polymerization followed by chemical grafting of drug compounds. J Mater Chem 2009, 19:3248-3252.
63. Patz TM, Doraiswamy A, Narayan RJ, Menegazzo N, Kranz C, Mizaikoff B, Zhong Y, Bellamkonda R, Bumgardner JD, Elder SH, et al. Matrix assisted pulsed laser evaporation of biomaterial thin films. Mater Sci Eng C Biomimetic Supramol Syst 2007, 27:514-522.
64. Piedade AP, Nunes J, Vieira MT. Thin films with chemically graded functionality based on fluorine polymers and stainless steel. Acta Biomater 2008, 4:1073-1080.
65. Enomoto K, Hasebe T, Asakawa R, Kamijo A, Yoshimoto Y, Suzuki T, Takahashi K, Hotta A. Controlling the drug release rate from biocompatible polymers with micro-patterned diamond-like carbon (DLC) coating. Diamond and Related Materials 2010, 19:806-813.
66. Lahann J, Klee D, Thelen H, Bienert H, Vorwerk D, Hocker H. Improvement of haemocompatibility of metallic stents by polymer coating. J Mater Sci Mater Med 1999, 10:443-448.
67. Hasebe T, Ishimaru T, Kamijo A, Yoshimoto Y, Yoshimura T, Yohena S, Kodama H, Hotta A, Takahashi K, Suzuki T. Effects of surface roughness on anti-thrombogenicity of diamond-like carbon films. Diamond Relat Mater 2007, 16:1343-1348.
68. Hasebe T, Shimada A, Suzuki T, Matsuoka Y, Saito T, Yohena S, Kamijo A, Shiraga N, Higuchi M, Kimura K, et al. Fluorinated diamond-like carbon as antithrombogenic coating for blood-contacting devices. J Biomed Mater Res A 2006, 76A:86-94.
69. Jordan SW, Chaikof EL. Novel thromboresistant materials. J Vasc Surg 2007, 45:104A-115A.
70. De S, Sharma R, Ali N, Mazumder MK. Enhancement of blood compatibility of implants by helium plasma treatment. In: Conference Record of the 2004 IEEE Industry Applications Conference, Vols 1-4-Covering Theory to Practice; 2004, 932-936.
71. Parker ER, Thibeault BJ, Aimi MF, Rao MP, MacDonald NC. Inductively coupled plasma etching of bulk titanium for MEMS applications. J Electrochem Soc 2005, 152:C675-C683.
72. Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A 2006, 76A:835-841.
73. Yin YB, Wise SG, Nosworthy NJ, Waterhouse A, Bax DV, Youssef H, Byrom MJ, Bilek MMM, McKenzie DR, Weiss AS, et al. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials 2009, 30:1675-1681.
74. Pypen CMJM, Plenk H, Ebel MF, Svagera R, Wernisch J. Characterization of microblasted and reactive ion etched surfaces on the commercially pure metals niobium, tantalum and titanium. J Mater Sci Mater Med 1997, 8:781-784.
75. Palmaz JC, Benson A, Sprague EA. Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 1999, 10:439-444.
76. Lu J, Rao MP, MacDonald NC, Khang D, Webster TJ. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater 2008, 4:192-201.
77. Lu J, Webster TJ. Endothelial cell adhesion on highly controllable compared to random nanostructured titanium surface features. In: Materials Research Society Symposium; 2007.
78. Choudhary S, Haberstroh KM, Webster TJ. Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng 2007, 13:1421-1430.
79. Samaroo HD, Lu J, Webster TJ. Enhanced endothelial cell density on NiTi surfaces with sub-macron to nanometer roughness. Int J Nanomed 2008, 3:75-82.
80. Choudhary S, Berhe M, Haberstroh KM, Webster TJ. Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo. Int J Nanomed 2006, 1:41-49.
81. Khang D, Lu J, Yao C, Haberstroh KM, Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials 2008, 29:970-983.
82. Thierry B, Winnik FM, Merhi Y, Silver J, Tabrizian M. Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules 2003, 4:1564-1571.
83. Yamauchi F, Koyamatsu Y, Kato K, Iwata H. Layer-by-layer assembly of cationic lipid and plasmid DNA onto gold surface for stent-assisted gene transfer. Biomaterials 2006, 27:3497-3504.
84. van Bommel KJC, Friggeri A, Mateman D, Geurts FAJ, van Leerdam KGC, Verboom W, van Veggel FCJM, Reinhoudt DN. Self-assembled monolayers on gold for the fabrication of radioactive stents. Adv Funct Mater 2001, 11:140-146.
85. Mahapatro A, Johnson DM, Patel DN, Feldman MD, Ayon AA, Agrawal CM. The use of alkanethiol self-assembled monolayers on 316L stainless steel for coronary artery stent nanomedicine applications: an oxidative and in vitro stability study. Nanomedicine 2006, 2:182-190.
86. Sargeant TD, Rao MS, Koh CY, Stupp SI. Covalent functionalization of NiTi surfaces with bioactive peptide amphiphile nanofibers. Biomaterials 2008, 29:1085-1098.
87. Tarcha PJ, Verlee D, Hui HW, Setesak J, Antohe B, Radulescu D, Wallace D. The application of ink-jet technology for the coating and loading of drug-eluting stents. Ann Biomed Eng 2007, 35:1791-1799.
88. Dibra A, Kastrati A, Mehilli J, Pache J, von Oepen R, Dirschinger J, Schomig A. Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Cathet Cardiovasc Interv 2005, 65:374-380.
89. Deuse T, Erben RG, Ikeno F, Behnisch B, Boeger R, Connolly AJ, Reichenspurner H, Bergow C, Pelletier MP, Robbins RC, et al. Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 2008, 200:126-134.
90. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model. Cathet Cardiovasc Interv 2006, 67:698-702.
91. Ye YW, Landau C, Willard JE, Rajasubramanian G, Moskowitz A, Aziz S, Meidell RS, Eberhart RC. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998, 26:398-408.
92. Wessely R, Hausleiter J, Michaelis C, Jaschke B, Vogeser M, Milz S, Behnisch B, Schratzenstaller T, Renke-Gluszko M, Stover M, et al. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 2005, 25:748-753.
93. Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, et al. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J 2005, 26:1475-1481.
94. Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O, Pache J, Wessely R, Schomig A, Kastrati A. Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 2008, 29:1975-1982.
95. Wieneke H, Dirsch O, Sawitowski T, Gu YL, Brauer H, Dahmen U, Fischer A, Wnendt S, Erbel R. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Cathet Cardiovasc Interv 2003, 60:399-407.
96. Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, Haberstroh J, Wnendt S, Virmani R, Hehrlein C. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Cathet Cardiovasc Interv 2005, 64:85-90.
97. Rajtar A, Kaluza GL. Hydroxyapatite-coated cardiovascular stents. EuroIntervention 2006, 2:113-115.
98. Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Maldonado G, Staico R, Siqueira D, Sousa AG, et al. 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC Cardiovasc Interv 2009, 2:422-427.
99. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, et al. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006, 47:1786-1795.
100. Klugherz BD, Jones PL, Cui XM, Chen WL, Meneveau NF, DeFelice S, Connolly J, Wilensky RL, Levy RJ. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000, 18:1181-1184.
101. Lin PH, Chronos NA, Marijianowski MM, Chen C, Bush RL, Conklin B, Lumsden AB, Hanson SR. Heparin-coated balloon-expandable stent reduces intimal hyperplasia in the iliac artery in baboons. J Vasc Interv Radiol 2003, 14:603-611.
102. Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, Tietz AB, Kirchmair R, Silver M, Curry C, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004, 110:36-45.
103. Swanson N, Hogrefe K, Javed Q, Gershlick AH. In vitro evaluation of vascular endothelial growth factor (VEGF)-eluting stents. Int J Cardiol 2003, 92:247-251.
104. Rossi ML, Zavalloni D, Gasparini GL, Mango R, Belli G, Presbitero P. The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol 2010, 141:e20-22.
105. Jin T, Zhu HH, Wu F, Yuan WE, Geng LL, Zhu H. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents. J Control Release 2008, 128:50-59.
106. Brito L, Amiji M. Nanoparticulate carriers for the treatment of coronary restenosis. Int Jf Nanomed 2007, 2:143-161.
107. Nakano K, Egashira K, Masuda S, Funakoshi K, Zhao G, Kimura S, Matoba T, Sueishi K, Endo Y, Kawashima Y, et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv 2009, 2:277-283.
108. Sarisozen C, Arica B, Atilla Hincal A, Calis S. Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation. J Microencapsul 2008:1-11.
109. Elkins CJ, Waugh JM, Amabile PG, Minamiguchi H, Sugimoto K, Ganaha F, Razavi MK, Dake MD. Development of a platform to evaluate and limit in-stent restenosis. Tissue Eng 2002, 8:395-407.
110. Ganaha F, Ohashi K, Do YS, Lee J, Sugimoto K, Minamiguchi H, Elkins CJ, Sameni D, Modanlou S, Kao EY, et al. Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study. J Vasc Interv Radiol 2004, 15:1287-1293.
111. Do YS, Kao EY, Ganaha F, Minamiguchi H, Sugimoto K, Lee J, Elkins CJ, Amabile PG, Kuo MD, Wang DS, et al. In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits. Radiology 2004, 230:377-382.
112. Rosengart AJ, Kaminski MD, Chen HT, Caviness PL, Ebner AD, Ritter JA. Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery. J Magnetism Magnetic Mater 2005, 293:633-638.
113. Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol Pharm 2009, 6:1380-1387.
114. Yellen BB, Forbes ZG, Halverson DS, Fridman G, Barbee KA, Chorny M, Levy R, Friedman G. Targeted drug delivery to magnetic implants for therapeutic applications. J Magnetism Magnetic Mater 2005, 293:647-654.
115. Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, Friedman G, Levy RJ. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steed stents. Proc Natl Acad Sci U S A 2008, 105:698-703.
116. Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, Sandhu GS. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol 2006, 48:1839-1845.